Magnetic Resonance Imaging of Changes in Abdominal Compartments in Obese Diabetics during a Low-Calorie Weight-Loss Program

PLoS One. 2016 Apr 25;11(4):e0153595. doi: 10.1371/journal.pone.0153595. eCollection 2016.

Abstract

Objectives: To investigate changes in the fat content of abdominal compartments and muscle area during weight loss using confounder-adjusted chemical-shift-encoded magnetic resonance imaging (MRI) in overweight diabetics.

Methods: Twenty-nine obese diabetics (10/19 men/women, median age: 59.0 years, median body mass index (BMI): 34.0 kg/m2) prospectively joined a standardized 15-week weight-loss program (six weeks of formula diet exclusively, followed by reintroduction of regular food with gradually increasing energy content over nine weeks) over 15 weeks. All subjects underwent a standardized MRI protocol including a confounder-adjusted chemical-shift-encoded MR sequence with water/fat separation before the program as well at the end of the six weeks of formula diet and at the end of the program at 15 weeks. Fat fractions of abdominal organs and vertebral bone marrow as well as volumes of visceral and subcutaneous fat were determined. Furthermore, muscle area was evaluated using the L4/L5 method. Data were compared using the Wilcoxon signed-rank test for paired samples.

Results: Median BMI decreased significantly from 34.0 kg/m2 to 29.9 kg/m2 (p < 0.001) at 15 weeks. Liver fat content was normalized (14.2% to 4.1%, p < 0.001) and vertebral bone marrow fat (57.5% to 53.6%, p = 0.018) decreased significantly throughout the program, while fat content of pancreas (9.0%), spleen (0.0%), and psoas muscle (0.0%) did not (p > 0.15). Visceral fat volume (3.2 L to 1.6 L, p < 0.001) and subcutaneous fat diameter (3.0 cm to 2.2 cm, p < 0.001) also decreased significantly. Muscle area declined by 6.8% from 243.9 cm2 to 226.8 cm2.

Conclusion: MRI allows noninvasive monitoring of changes in abdominal compartments during weight loss. In overweight diabetics, weight loss leads to fat reduction in abdominal compartments, such as visceral fat, as well as liver fat and vertebral bone marrow fat while pancreas fat remains unchanged.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Complications / diagnostic imaging*
  • Energy Intake*
  • Humans
  • Magnetic Resonance Imaging
  • Obesity / complications
  • Obesity / diagnostic imaging*
  • Obesity / diet therapy
  • Prospective Studies
  • Weight Reduction Programs*

Grants and funding

Two authors of this manuscript declare relationships with the following companies: LJV and JK received a Gerhard Domagk scholarship from University Medicine Greifswald made possible through an unrestricted educational grant from Baxter Deutschland GmbH (Unterschleissheim, Germany), Medinal GmbH (Greven, Germany) and Nutricia GmbH (Erlangen, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors have no conflict of interests. In addition, this study has received funding by Nestlé HealthCare Science GmbH. The standardized weight-loss program OPTIFAST® was used with the consent of Nestlé HealthCare Science GmbH. Nestlé HealthCare Science GmbH supported the study by granting study participants a 15% discount for the formula diet.